| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |